C-Type Lectin Domain Family 12, Member A (CLEC12A) ELISA Kits

CLEC12A encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Zusätzlich bieten wir Ihnen CLEC12A Antikörper (83) und CLEC12A Proteine (7) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
CLEC12A 160364 Q5QGZ9
CLEC12A 232413 Q504P2
Anti-Ratte CLEC12A CLEC12A 680338  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top CLEC12A ELISA Kits auf antikoerper-online.de

Showing 2 out of 6 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Human 0.094 ng/mL 0.15 ng/mL - 10 ng/mL A typical standard curve 96 Tests Anmelden zum Anzeigen 13 bis 16 Tage
Maus < 46.9 pg/mL 78 pg/mL - 5000 pg/mL   96 Tests Anmelden zum Anzeigen 11 bis 18 Tage

Weitere ELISA Kits für CLEC12A Interaktionspartner

Human C-Type Lectin Domain Family 12, Member A (CLEC12A) Interaktionspartner

  1. Enumeration of circulating hMICL+ stem cells by flow cytometry can discriminate between myeloproliferative neoplasm phenotypes and holds potential for monitoring disease evolution.

  2. CLL-1 is a novel prognostic predictor that could be exploited to supplement the current acute myeloid leukemia prognostic risk stratification system.

  3. BMI-1, TIM-3 and CLL-1 have roles in acute myeloid leukemia prognosis and therapy

  4. The CLEC12A is an effective new candidate with great potential for in vivo Ag delivery into mDCs and pDCs, thereby using the specialized functions and cross-talk capacity of these DC subsets to boost tumor-reactive T cell immunity in cancer patients.

  5. Due to the absence of CLEC12A on normal haematopoietic stem cells, CLEC12A stem cell immunophenotyping may contribute to diagnosing and monitoring MDS patients and could furthermore add knowledge about disease propagating cells in MDS.

  6. We propose the hypothesis that decreased expression of CLEC12A is a common denominator in the hyperinflammatory responses observed in Behcet's syndrome and gout.

  7. Antibacterial autophagy is impaired in CLEC12A-deficient cells, and this effect is exacerbated in the presence of the ATG16L1( *)300A risk allele.

  8. Upon CLL1-selective binding of this fusion protein, granulocytes acquire additional TRAIL-mediated cytotoxic activity that, importantly, potentiates antibody-mediated cytotoxicity of clinically used therapeutic antibodies

  9. We conclude the hMICL/CD123-based MFC assay is a promising MRD tool in AML.

  10. There is a potential genetic association of CLEC12A with rheumatoid arthritis (RA). Since CLEC12A encodes for the myeloid inhibitory C-type lectin-like receptor that modulates cytokine synthesis, this receptor may contribute to the pathogenesis of RA.

  11. For production of cytotoxic T cells, transgenic DEC-205 and Clec9A, but not Clec12A, are effective targets for antibody-mediated delivery of antigens for vaccination, although only in the presence of adjuvants.

  12. MICL is a negative regulator of granulocyte and monocyte function

  13. the molecular cloning, tissue distribution, and functional characterization of a novel NK cell receptor, KLRL1, from human and mouse dendritic cells [KLRL1]

  14. Expression cloning identified the antigen recognized as C-type lectin-like molecule-1, a previously undescribed transmembrane glycoprotein

  15. Dendritic-cell (DC)-associated C-type lectin receptors (CLRs) take up antigens to present to T cells and regulate DC functions.

  16. human MICL may be involved in the control of myeloid cell activation during inflammation

  17. CLL-1 expression is also present on the CD34(+)CD38(-) stem- cell compartment in acute myeloid leukemia

  18. mMICL recognises an endogenous ligand in a variety of murine tissues, suggesting that the receptor plays a role in homeostasis

  19. Anti-Clec12A mAb alone produced only moderate responses, but these were amplified by coinjecting only small amounts of LPS as a dendritic cell activation agent

CLEC12A Antigen-Profil

Beschreibung des Gens

This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signaling, glycoprotein turnover, and roles in inflammation and immune response. The protein encoded by this gene is a negative regulator of granulocyte and monocyte function. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. This gene is closely linked to other CTL/CTLD superfamily members in the natural killer gene complex region on chromosome 12p13.

Genbezeichner und Symbole assoziert mit CLEC12A

  • C-type lectin domain family 12 member A (CLEC12A) Antikörper
  • C-type lectin domain family 12, member a (Clec12a) Antikörper
  • C-type lectin domain family 12, member A (Clec12a) Antikörper
  • CLL-1 Antikörper
  • CLL1 Antikörper
  • D230024O04 Antikörper
  • DCAL-2 Antikörper
  • KLRL1 Antikörper
  • MGC179455 Antikörper
  • Micl Antikörper

Bezeichner auf Proteinebene für CLEC12A

C-type lectin domain family 12, member A , C-type lectin domain family 12 member A , C-type lectin protein CLL-1 , C-type lectin superfamily , C-type lectin-like molecule-1 , dendritic cell-associated lectin 2 , myeloid inhibitory C-type lectin-like receptor , C-type lectin-like molecule 1

477697 Canis lupus familiaris
508740 Bos taurus
100053711 Equus caballus
160364 Homo sapiens
232413 Mus musculus
680338 Rattus norvegicus
Ausgewählte Anbieter für CLEC12A (CLEC12A) ELISA Kits
Haben Sie etwas anderes gesucht?